Acrivon Therapeutics, Inc. — Investor Relations & Filings
Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company's core technology is its proprietary Acrivon Predictive Precision Proteomics (AP3) platform, which uses proteomics to identify the biologic drivers of cancer in individual patients. This platform enables the development of OncoSignature companion diagnostic tests designed to match patients with therapies predicted to be most effective for their specific tumor biology, a method distinct from genomic-based approaches. Acrivon's pipeline focuses on DNA Damage Response and cell cycle regulators. Its lead drug candidate, ACR-368 (prexasertib), is a selective kinase inhibitor in Phase 2 clinical trials for multiple solid tumor types. The pipeline also includes ACR-2316, a dual WEE1/PKMYT1 inhibitor. The company leverages its AP3 platform for internal drug development and for strategic co-development partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2024 | 2024-02-13 | English | |
| Director's Dealing 2024 | 2024-02-09 | English | |
| Director's Dealing 2024 | 2024-02-09 | English | |
| 8-K | 2024-02-08 | English | |
| Director's Dealing 2024 | 2024-01-19 | English | |
| Director's Dealing 2024 | 2024-01-16 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
8 filings
| |||||
| 13187426 | Major Shareholding Notification 2024 | 2024-02-13 | English | ||
| 13187428 | Director's Dealing 2024 | 2024-02-09 | English | ||
| 13187427 | Director's Dealing 2024 | 2024-02-09 | English | ||
| 13187429 | 8-K | 2024-02-08 | English | ||
| 13187430 | Director's Dealing 2024 | 2024-01-19 | English | ||
| 13187431 | Director's Dealing 2024 | 2024-01-16 | English | ||
| 13187433 | Director's Dealing 2024 | 2024-01-12 | English | ||
| 13187432 | 8-K | 2024-01-08 | English | ||
|
2023
7 filings
| |||||
| 13187434 | Regulatory Filings 2023 | 2023-12-18 | English | ||
| 13187435 | Regulatory Filings 2023 | 2023-12-12 | English | ||
| 13187438 | 8-K | 2023-12-08 | English | ||
| 13187436 | Regulatory Filings 2023 | 2023-12-05 | English | ||
| 13187437 | S-3 | 2023-12-01 | English | ||
| 13187439 | Director's Dealing 2023 | 2023-11-17 | English | ||
| 13187440 | Director's Dealing 2023 | 2023-11-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Acrivon Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34507/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34507 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34507 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34507 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34507}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Acrivon Therapeutics, Inc. (id: 34507)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.